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Abstract
Background: Early detection of lung diseases can help to reduce their severity. Lung diseases are among the most
frequently occurring and serious diseases worldwide; nonetheless, many patients remain undiagnosed. Preventive
health checks including spirometry can detect lung diseases at early stages; however, recruitment for health checks
remains a challenge, and little is known about what motivates the attendance.
The aim of the study is to examine whether focused information on spirometry in the invitation compared to general
information will impact the attendance rate in preventive health checks.
Methods/design: This randomized, controlled trial tests the effect of information on spirometry embedded in the Check
your Health Preventive Program (CHPP). The CHPP is an open-label, household cluster-randomized, controlled trial
offering a preventive health check to 30- to –49-year-olds in a Danish municipality from 2012 to 2017 (n= 26,216). During
2015–2016, 4356 citizens aged 30–49 years will be randomized into two groups. The intervention group receives an
invitation which highlights the value and contents of spirometry as part of a health check and information about lung
diseases. The comparison group receives a standard invitation containing practical information and specifies the contents
of the general health check.
Outcomes are (1) differences in attendance rates measured by the proportion of citizens attending each of the two
study groups and (2) proportion of persons at risk defined by smoking status and self-reported lung symptoms in the
study groups. The proportion of participants with abnormal spirometry assessed at the preventive health check will be
compared between the two study groups.
Discussion: The results from the present study will inform future recruitment strategies to health checks. The developed
material on content, value, and information about lung disease is feasible and transferable to other populations, making it
easy to implement if effective.
Trial registration: ClinicalTrials.gov: NCT02615769. Registered on 25 November 2015.
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Background
Early detection of lung diseases can help reduce the severity
of these diseases when inflicted. Lung diseases are among
the most frequently occurring and serious conditions in the
western world, including Denmark [1]. The Danish Health
Authority recommends spirometry every second year to all
individuals older than 35 years with at least one respiratory
symptom and/or exposure to any known risk factor
(smoke, genetics, air pollution, chemical fumes, or dust) in
order to facilitate early case finding of chronic obstructive
pulmonary disease (COPD) [2]. However, an estimated
200,000 Danish citizens (50%) with COPD remain undiag-
nosed and unknown to the health care system [2, 3].
Preventive health checks including spirometry can be
used to detect lung diseases at early stages. However, a
well-known challenge is low uptake, especially in people
at risk of developing disease [4]. Previous studies of at-
tendees in preventive health checks [5] reported average
attendance rates from 18 to 82%. They also showed that
non-attendees were less healthy than the attendees and
that those least likely to attend health checks were youn-
ger, single men with low income or low socioeconomic
status, active smokers, or the unemployed or less educated
[5]. Little is known about what motivates the attendance
to health checks.
In a systematic review by Jepson et al., interventions used
to increase uptake in screening for a variety of conditions
are compared in 190 trials [6]. These interventions targeted
individuals and revealed enhanced invitation procedures.
An appointment in the invitation letter, telephone calls, and
reminders seemed to increase the participation rate effect-
ively [6]. A few studies evaluated the effect of providing
additional information in the invitation. Kiernan et al. ex-
amined three strategies of recruiting citizens into trials by
personalizing the invitation letter and by adding additional
information. They found that a personalized letter includ-
ing heart disease risk statistics did not yield a higher re-
sponse rate than the standard letter [7]. Sallis et al.
compared an enhanced invitation letter applying behavioral
insights with a standard invitation letter and found a differ-
ence in the participation rate from 29.3% to 33.5% [8]. Van
Wonderen et al. found that neither the rank of the individ-
ual signing a subsequent detailed information letter nor the
use of an official funding agency logo on the study’s initial
invitation made an impact on patient attendance [9]. Finally
Martinson et al. showed a difference in response rate from
55% to 69% using monetary incentives for recruiting ado-
lescents to a trial focusing on smoking cessation [10].
In studies aiming to improve participation in colorec-
tal cancer screening, enhanced invitation letters and leaf-
lets have yielded an increase in participation of up to 6%
[11, 12]. Recently, Quaife et al. [13] published a study
protocol to test the hypothesis that targeted invitation
strategy will increase the uptake in a lung cancer
screening compared with a standard invitation. This
population consisted of patients aged 60–75 with a
known smoking history. To our best knowledge, no tri-
als aimed to increase the attendance in general health
checks by including information on the benefits of
measuring spirometry, and only a few studies have in-
cluded spirometry in a preventive health check [14, 15].
The aim of the present study is to examine whether
focused information about spirometry in the invitation
material will influence the attendance rate in preventive
health checks. We also aim to describe the characteris-
tics of the attendees and non-attendees. We hypothesize
that information on spirometry as part of the invitation
material for the preventive health check will increase the
overall attendance rate by 5 percentage points and also
that more people at risk will attend. The study protocol
conforms to the Consolidated Standards Of Reporting
Trials (CONSORT) statement [16] and the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) 2013 statement [17]. See Additional files
1 and 2 [17]. This paper will follow the CONSORT ex-
tension for non-pharmacological interventions and clus-
ter trials [18, 19].
Methods/design
Trial design
The trial is an open-label, household cluster-randomized,
controlled trial with a two-group parallel design. The trial
is embedded in the fourth year (2015–2016) of the on-
going Check your Health Preventive Program (CHPP)
[20]. The CHPP offers a preventive health check to all 30-
to 49-year-old citizens in a Danish municipality during the
years 2012–2017 (n = 26,216).
We began designing the present study in January
2015, the recruitment started in November 2015, and we
expect it to be completed in December 2016.
Population
The citizens are randomized by household into five
groups of equal size, each representing the specific year
they are invited to attend a health check. Citizens ran-
domized for group 4 (n = 5205) are eligible for the
present trial (Fig. 1). The Danish Civil Registration Sys-
tem (CRS) [21, 22] was used to identify all citizens liv-
ing in the municipality of Randers aged 30–49 years on
1 January 2012 included in the CHPP. The CRS is an
administrative register containing individual-level in-
formation including the unique and permanent ten-
digit civil personal registration (CPR) number on all
persons residing in Denmark [21, 22]. The only exclu-
sion criterion is terminal illness as reported by a
general practitioner [20].
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Setting
The health checks and the subsequent health behavioral
programs are conducted at a local health care center.
The subsequent health interview takes place at the par-
ticipant’s own general practitioner’s office. To ensure
standardization and quality, the health checks are con-
ducted by health professionals experienced in risk com-
munication and conduction measurement procedures.
Questionnaire
Prior to the health check, the participants are asked to
answer a web-based questionnaire regarding self-rated
health [23], mental health [23], alcohol consumption
[24], physical activity, and smoking habits using items
from the Danish National Health Profile questionnaire
[25]. The question concerning lung symptoms is a modi-
fied version of the question from the Clinical COPD
Questionnaire [26] (Table 1). The participants are also
asked which element of the preventive health check has
their highest interest (not shown).
Spirometry
Lung function will be assessed using the EasyOne Diag-
nostic Spirometer (Ndd Medical Technologies, Andover,
MA, USA), which is calibrated daily. The spirometer
measures forced expiratory volume in one second
(FEV1) and forced vital capacity (FVC). Spirometer soft-
ware calculates the FEV1/FVC ratio and the predicted
value of FEV1 based on reference values. At each exam-
ination, the criterion for correct procedure performance
is at least three measurements differing by less than 5%.
Reversibility using a bronchodilator is not allowed.
Abnormal spirometry is defined as FEV1/FVC <0.7 or
FEV1% pred. <0.8 or FVC % pred. <0.8. The spirometric
cut-off values used in the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) guidelines [27, 28]
will be used for classifying disease severity.
The health check
In addition to spirometry, the clinical examination in-
cludes the following measurements: blood analysis of
total cholesterol, low-density lipoprotein (LDL), glycated
hemoglobin (HbA1c), systolic and diastolic blood pres-
sure, bodyweight, height, and Astrand’s submaximal bike
test (cardiorespiratory fitness) [20, 29]. After the health
Fig. 1 Flowchart of participants in the Check your Health Preventive Program [20] and the present trial. R1 household randomization into five groups
of equal size, R2 household randomization into the intervention group or comparison group in the present study before sending of the invitations
Table 1 Items and response categories from the questionnaire
Do you smoke? • Yes, daily
• Yes, at least once a week
• Yes, occasionally
(part-time smoker)
• No, I quit in (year)
• No, I have never smoked
On average, how much do
you smoke daily?
• Number of cigarettes
• Number of cheroots
• Number of cigars
• Number of pipes
During the past 4 weeks, how much
of the time were you troubled by dyspnea,
wheezing or coughing? (only one x)
• All of the time
• Most of the time
• Now and then
• Rarely
• Not at all
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check, the results are presented in a profile pamphlet in-
cluding recommendations for follow-up according to the
citizen’s risk profile. Citizens with abnormal spirometry
are recommended to consult their general practitioner
for further examination. Execution of the health check is
standardized by a written standardized operational pro-
cedure (SOP), and adherence is monitored continuously.
The average attendance rate in the CHPP was 53% dur-
ing 2012–2015.
National registers
In Denmark we have a unique opportunity to link study
measurements to nationwide medical registers and data-
bases [21, 22]. To understand the processes involved in
responding to the intervention, especially among the non-
attendees, secondary characteristics regarding sociodemo-
graphics, redeemed medication, and consultations at their
general practitioner will be obtained by linking to Danish
registers [21, 30, 31].
The routine procedure for invitation
The comparison group (n = 2178) receives a standard invi-
tation and a leaflet, as shown in Additional file 3. The leaflet
and invitation contain practical information and specify the
contents of the general health check [20]. The invitation
also refers to the homepage for further information. Letters
are dispatched continuously with a prefixed appointment
for the health check. The appointment can be accepted,
modified, or rejected via the Internet or by phone. A re-
minder is sent out with a new appointment time, if the ap-
pointment is not accepted within 7 days. Failure to reply
within 3 weeks procures another reminder.
The intervention
The intervention group (n = 2178) receives a modified invi-
tation and a leaflet which highlights the benefits of spirom-
etry as part of a health check and provides information
about how to prevent lung diseases. The invitation was de-
veloped in collaboration with the Danish Lung Association
and was tested for content and comprehensibility on a
focus group before dispatch of the invitations to the inter-
vention group. The citizens are recommended to visit the
homepage for further information and advice on how to
prevent lung diseases [32]. All the material can be accessed
in Additional file 3.
Randomization
Randomization is performed on clusters defined by house-
holds based on addresses from the Danish Civil Register
[21, 22]. Furthermore, the randomization is balanced at the
general practitioner (GP) level to ensure distribution of the
follow-up workload over 5 years. Using the same index in-
dividual per households, 4356 citizens randomized to group
4 in the CHPP are further randomized by household into
two parallel groups: intervention or comparison (Fig. 1).
Randomization is handled by an independent statistician.
Implementation and booking are handled by a data man-
ager. The intervention, the outcome, and the group assign-
ment are not revealed to the participants, And the health
care professionals also remain blinded. The blinding will be
unlocked as the last spirometry measurement is done in
December 2016.
Outcome
The outcomes are (1) differences in attendance rates mea-
sured by the proportion of citizens attending each of the
two study groups and (2) proportion of persons at risk de-
fined by smoking status and self-reported lung symptoms
in the study groups. Furthermore, the characteristics of the
two groups will be described according to sex, age, smoking
history, and self-reported lung symptoms. Smoking status
will be classified as smoker, ex-smoker, or never a smoker.
The proportion of participants with abnormal spirometry
assessed at the preventive health check will be compared
between the two study groups.
Sample size
The sample size is estimated at 4356 participants in total
and is calculated on the basis of the following assumptions:
1:1 randomization, two-sided significance level of 0.05,
power of 0.9, intra-cluster correlation coefficient of 0.01;
and with an average of 1.5 citizens in each household, we
calculated the design effect [33] to be 1.05. Calculations are
further based on the objective of being able to detect a dif-
ference of 5 percentage points in effect size based on an at-
tendance rate of 53–58%. The investigators determined this
5 percentage point difference to be clinically meaningful
based on expert opinion [7–9, 34] and based on the run-in
period where the participation rate was 53%. Also, an in-
crease of 5 percentage points would deliver clinically mean-
ingful benefit if scaled in a nationwide program. In order to
reflect a possible clustering effect of the general practi-
tioners (n = 46), which seldom exceeds 0.01 in primary care
settings [35], the intra-cluster correlation coefficient was
included. To limit the missing data in our study [36],
incomplete questionnaires and incomplete spirometry
measurements will be excluded. Non-attendees will be de-
scribed with information supplied from national registers
[21, 22]. A sensitivity analysis will also be performed.
Statistics
The effect of the intervention on attendance will be esti-
mated by the difference of the proportion of citizens at-
tending each of the groups. Furthermore, a descriptive
analysis of attendees and non-attendees will be per-
formed regarding sex, age, smoking history, self-reported
lung symptoms, and spirometry measurements. The ana-
lysis will follow the intention-to-treat principle [16].
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For the descriptive part of this study, bivariate and multi-
variate analyses will be performed. Numerical variables are
presented as mean ± standard deviation, and binary vari-
ables as absolute numbers and relative (percent) frequen-
cies. Student’s t test will be used when comparing means
or changes in means of numerical variables, and Fisher’s
exact t test or the chi-squared test will be used when com-
paring proportions for binary variables. Binary outcomes
will be analyzed with logistic regression. The statistical sig-
nificance level is set at p < 0.05. Statistical analysis will be
performed using Stata 14.0 software [37]. A detailed Statis-
tical Analysis Plan will be finalized before access to the data
and will be attached to the ClinicalTrials.gov trial identifier
(NCT02615769).
Discussion
This study is the first to examine the benefits of a low-cost
and enhanced invitation strategy to identify lung impair-
ment among young adults in a real-world setting. It is de-
signed as a pragmatic and randomized study and will
provide information which can be used directly by health
care planners in the decision of how to implement health
checks. The outcomes were chosen to mirror the aims of
the intervention: the overall attendance rate and the attend-
ance of people at risk for lung impairment.Our recruitment
strategy is to reach the citizens in three different ways: by
webpage, leaflet, and invitation letter in a randomized con-
trolled design. Prior studies have shown an increase in at-
tendance by enhancing invitation material [9, 11, 12, 38].
Therefore, we expect an increase in the attendance of 5
percentage points, and we also expect that more people at
risk will attend. We believe it is a realistic goal, even though
previous studies indicate that smokers feel ashamed and
guilty of their self-inflicted disease and therefore hesitate to
seek help [4]. In order to avoid having smokers absent
themselves, when we were designing the new material for
the intervention group, we involved a communications
consultant from the Danish Lung Association [39], who is
an expert in content and comprehensibility.
Strengths and limitations
Participants will be enrolled directly from the general
population; therefore, they will not receive any screening
prior to inclusion. Thus, the generalizability will not only
reflect certain at-risk populations such as current
smokers, prior smokers, or citizens with chronic disease.
The high transferability of the invitation material and
the application of the intention-to-treat principle pro-
vide a high external validity. Moreover, the objective
measure of attendance contributes with a high internal
validity. We chose cluster randomization by household
to limit the expected contamination between attendees
living together, because motivation to attend a health
check will potentially impact the entire household. To
avoid having attendees refuse to participate, households
are invited together and two reminders are sent out. Fur-
thermore, appointments are scheduled outside of work
hours. Finally, we have the unique opportunity to use
the Danish registers as a population-based health care
database with information about the non-attendees [21].
The present study has some limitations. Firstly, we are
aware that both groups have the same accessibility to
the webpage regarding how to prevent lung disease, and
this may dilute the difference between the two groups.
Secondly, the right level of extra information is difficult
to achieve. Too much information may cause the partici-
pants to believe that the study is only about lung func-
tion and possibly scare some of the citizens at risk. On
the other hand, too little preventive information may di-
lute the intervention. Thirdly, we have no spirometry
measurements on the non-attendees, which complicates
the comparison among the non-attendees and the at-
tendees. Nonetheless, we have the opportunity to supply
the characteristics of the non-attendees by redeemed
medication and sociodemographic characteristics by the
Danish registers [21, 31]. Although our population is
fairly young, the most severely affected and chronic pa-
tients will not show up for the examination as it requires
some physical and mental effort, but we expect the effect
to be equal among the two groups. Finally, there is a risk
of misclassification among, e.g., citizens with flu or
pneumonia, thus resulting in false positive outcomes.
However, this risk is expected to be equal among the
two groups due to the randomization.
Perspectives
Lung diseases represent a significant burden for patients
and health care systems worldwide. Optimizing early
detection followed by pharmacological and non-
pharmacological interventions can not only improve a
patient’s health status and quality of life, but can also re-
duce health care expenses. The results from the present
study are expected to contribute important knowledge
about the value of information on spirometry in invita-
tions to health checks.
Trial status
At the time of submission of this manuscript, the trial
has enrolled approximately 3500 participants. Recruit-
ment is ongoing.
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Additional file 2: SPIRIT figure. (DOC 48 kb)
Additional file 3: Invitation, leaflet, and website text to the invitation
and comparison group. (PDF 4057 kb)
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